Literature DB >> 15704657

Magnetocardiograms in clinical medicine: unique information on cardiac ischemia, arrhythmias, and fetal diagnosis.

Satsuki Yamada1, Iwao Yamaguchi.   

Abstract

Cardiac diseases are the leading cause of death in population. Diagnostic tests to detect cardiac dysfunction at an early stage of the disease are desirable. The major focus has been centered on tests evaluating the perfusion of the heart with imaging techniques or detecting alterations in electrical or mechanical function of the heart. The heart generates magnetic fields that can be detected by body surface mapping utilizing super conducting quantum interference device sensors giving magnetocardiograms (MCGs). The advantages of MCG over traditional electrocardiograms (ECGs) are increased sensitivity to small signals and lack of conductivity in body tissues, presentation of direct component signals and primary currents. This review will highlight the basic principles and recent advantages of MCGs, and the application of MCG in clinical diagnosis, especially in cases whose ECGs are non-diagnostic or not specific, such as detecting baseline shift in ischemic heart disease, noninvasive His potential recording, detection of arrhythmic mechanism defining reentrant circuits vs non reentrant mechanism, diagnosis of fetal arrhythmias and prolongation of QT interval. Areas of future basic and clinical research are also discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15704657     DOI: 10.2169/internalmedicine.44.1

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Magnetocardiography provides non-invasive three-dimensional electroanatomical imaging of cardiac electrophysiology.

Authors:  Riccardo Fenici; Donatella Brisinda
Journal:  Int J Cardiovasc Imaging       Date:  2006-05-18       Impact factor: 2.357

2.  Standard template of adult magnetocardiogram.

Authors:  Akihiko Kandori; Kuniomi Ogata; Tsuyoshi Miyashita; Yasushi Watanabe; Kimio Tanaka; Masahiro Murakami; Yuji Oka; Hiroshi Takaki; Syuji Hashimoto; Yuko Yamada; Kazuo Komamura; Wataru Shimizu; Shiro Kamakura; Shigeyuki Watanabe; Iwao Yamaguchi
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

3.  Vector magnetocardiography measurement with a compact elliptically polarized laser-pumped magnetometer.

Authors:  Wenqiang Zheng; Shengran Su; Guoyi Zhang; Xin Bi; Qiang Lin
Journal:  Biomed Opt Express       Date:  2020-01-07       Impact factor: 3.732

4.  Predictive value of unshielded magnetocardiographic mapping to differentiate atrial fibrillation patients from healthy subjects.

Authors:  Gianluigi Guida; Anna Rita Sorbo; Riccardo Fenici; Donatella Brisinda
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-27       Impact factor: 1.468

5.  Subtraction magnetocardiogram for detecting coronary heart disease.

Authors:  Akihiko Kandori; Kuniomi Ogata; Tsuyoshi Miyashita; Hiroshi Takaki; Hideyuki Kanzaki; Syuji Hashimoto; Wataru Shimizu; Shiro Kamakura; Shigeyuki Watanabe; Kazutaka Aonuma
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

6.  Data mining of magnetocardiograms for prediction of ischemic heart disease.

Authors:  Yosawin Kangwanariyakul; Chanin Nantasenamat; Tanawut Tantimongcolwat; Thanakorn Naenna
Journal:  EXCLI J       Date:  2010-06-30       Impact factor: 4.068

7.  A portable prototype magnetometer to differentiate ischemic and non-ischemic heart disease in patients with chest pain.

Authors:  Shima Ghasemi-Roudsari; Abbas Al-Shimary; Benjamin Varcoe; Rowena Byrom; Lorraine Kearney; Mark Kearney
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

8.  Magnetocardiography for identification of coronary ischemia in patients with chest pain and normal resting 12-lead electrocardiogram.

Authors:  Raja Ramesh; Sengottuvel Senthilnathan; Santhosh Satheesh; Pragyna Parimita Swain; Rajesh Patel; Ajith Ananthakrishna Pillai; Gireesan Katholil; Raja J Selvaraj
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-06       Impact factor: 1.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.